An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

Tsuji, M., Nair, M. S., Masuda, K., Castagna, C., Chong, Z., Darling, T. L., Seehra, K., Hwang, Y., Ribeiro, Á. L., Ferreira, G. M., Corredor, L., Coelho-dos-Reis, J. G. A., Tsuji, Y., Mori, M., Boon, A. C. M., Diamond, M. S., Huang, Y., & Ho, D. D. (2023). An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-39738-1
Authors:
Moriya Tsuji
Manoj S. Nair
Kazuya Masuda
Candace Castagna
Zhenlu Chong
Tamarand L. Darling
Kuljeet Seehra
Youngmin Hwang
Ágata Lopes Ribeiro
Geovane Marques Ferreira
Laura Corredor
Jordana Grazziela Alves Coelho-dos-Reis
Yukiko Tsuji
Munemasa Mori
Adrianus C. M. Boon
Michael S. Diamond
Yaoxing Huang
David D. Ho
Affiliated Authors:
Moriya Tsuji
Manoj S. Nair
Kazuya Masuda
Candace Castagna
Youngmin Hwang
Laura Corredor
Yukiko Tsuji
Munemasa Mori
Yaoxing Huang
David D. Ho
Subjects:
Publication Type:
Article
Unique ID:
10.1038/s41467-023-39738-1
PMID:
Publication Date:
Data Source:
Scopus

Record Created: